Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines
Related Experiment Video
Updated: Oct 17, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
1Department of Dermatology, Massachusetts General Hospital and Dana-Farber/Partners CancerCare, Boston 02114, USA.
Abstract:
Both inactivation of the tumor suppressor gene, PTEN/MMAC1, and oncogenic activation of RAS have been described in human cutaneous melanoma. In mice, activation of a RAS-containing pathway is a necessary step in the pathogenesis of murine melanomas. Because PTEN negatively regulates on the downstream effects of phosphatidylinositol-3-kinase (PI3-K), we hypothesized that the loss of PTEN/MMAC1 and the activation of RAS may be largely equivalent because RAS is a known positive upstream regulator of PI3-K. We expanded our previous survey of PTEN/MMAC1 mutations and analyzed the RAS status of 53 cutaneous melanoma cell lines, 18 glioma cell lines, and 17 uncultured cutaneous melanoma metastasis. Overall, 51% of the cell lines had alterations in either PTEN/MMAC1 or RAS. We found 16 cell lines (30%) with alterations in PTEN/MMAC1 and 11 cell lines (21%) with activating NRAS mutations; only 1 cell line had concurrent alterations in both genes. Moreover, glioma cell lines with a high frequency of PTEN/MMAC1 inactivation had no identifiable RAS alterations. Ectopic expression of PTEN in several cutaneous melanoma cell lines suppressed colony formation irrespective of PTEN/MMAC1 status; furthermore, PTEN expression in cell lines carrying activated RAS also suppressed colony formation. The relative reciprocity of PTEN/MMAC1 abrogation and NRAS activation suggests that the two genetic changes, in a subset of cutaneous melanomas, are functionally overlapping.
Insights
Loss of the PTEN/MMAC1 tumor suppressor gene and activation of RAS signaling are common in melanoma. These genetic changes appear functionally overlapping, suggesting they can act similarly in melanoma development.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- PTEN/MMAC1 inactivation and RAS activation are implicated in human cutaneous melanoma.
- RAS pathway activation is crucial for murine melanoma development.
- PTEN negatively regulates phosphatidylinositol-3-kinase (PI3-K) signaling.
Purpose of the Study:
- To investigate the relationship between PTEN/MMAC1 and RAS alterations in melanoma.
- To determine if PTEN/MMAC1 loss and RAS activation are functionally equivalent in melanoma pathogenesis.
Main Methods:
- Analysis of PTEN/MMAC1 mutations and RAS status in 53 cutaneous melanoma cell lines, 18 glioma cell lines, and 17 uncultured melanoma metastases.
- Ectopic expression of PTEN in melanoma cell lines to assess its effect on colony formation.
- Correlation analysis of genetic alterations and gene expression patterns.
Main Results:
- 51% of analyzed cell lines exhibited alterations in either PTEN/MMAC1 or RAS.
- 16 cell lines (30%) had PTEN/MMAC1 alterations, and 11 (21%) had activating NRAS mutations.
- PTEN re-expression suppressed colony formation, regardless of PTEN/MMAC1 status or RAS activation, indicating functional overlap.
Conclusions:
- PTEN/MMAC1 abrogation and NRAS activation are functionally overlapping genetic events in a subset of cutaneous melanomas.
- These findings suggest that targeting the PI3-K pathway could be a therapeutic strategy for melanomas with either PTEN/MMAC1 or RAS alterations.
- Glioma cell lines showed high PTEN/MMAC1 inactivation but no RAS alterations, suggesting distinct roles in different cancers.
Related Concept Videos
Abnormal Proliferation
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
